5-membered heterocycle-based p38 kinase inhibitors

Details for Australian Patent Application No. 2004259662 (hide)

Owner Novartis AG

Inventors Fryszman, Olga M.; Lang, Hengyuan; Chang, Edcon; Fang, Yunfeng; Lan, Jiong

Agent Davies Collison Cave

Pub. Number AU-B-2004259662

PCT Pub. Number WO2005/009973

Priority 60/560,481 07.04.04 US; 60/499,054 29.08.03 US; 60/483,428 26.06.03 US

Filing date 24 June 2004

Wipo publication date 3 February 2005

Acceptance publication date 7 August 2008

International Classifications

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 231/38 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 231/44 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 231/52 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 233/88 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/10 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2005/009973 Priority application(s): WO2005/009973

7 August 2008 Application Accepted

  Published as AU-B-2004259662

4 December 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004259664-17-acetamido-4-azasteroid derivatives as androgen receptor modulators

2004259661-Prodrugs of 9-aminomethyl tetracycline compounds